Safety and Efficacy of ALV003 for the Treatment of Celiac Disease

NCT00959114 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

BIOLOGICAL: ALV003
BIOLOGICAL: ALV003 placebo

Sponsor

Alvine Pharmaceuticals Inc.